• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1997 Fiscal Year Final Research Report Summary

STUDY ON TUMOR MARKER OF SALIVARY GLAND

Research Project

Project/Area Number 07672048
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 病態科学系歯学(含放射線系歯学)
Research InstitutionEHIME UNIVERSITY

Principal Investigator

HAMAKAWA Hiroyuki  Department of Oral & Maxillofacial Surgery, Ehime University School of Medicine, Associate professor, 医学部, 助教授 (20127905)

Co-Investigator(Kenkyū-buntansha) TANIOKA Hiroaki  Department of Oral & Maxillofacial Surgery, Ehime University School of Medicine,, 医学部, 教授 (10028748)
Project Period (FY) 1995 – 1997
KeywordsSalivary gland Neoplasms / tumor marker / cytokeratin / Monoclonal antibody / CYFRA21-1 / telomerase
Research Abstract

[Materials and Methods]
Expression of keratin family in the normal salivary gland was analyzed to develop a specific tumor marker of the salivary gland neoplasms. Cytokeratin protein was extracted and purified from the normal submandibular gland and its neoplasms. Monoclonal antibodies against cytokeratin polypeptide were developed by cell fusion method. Species specificity of cytokeratins were immunohistochemically studied as a basic research for establishing an animal model of the salivary gland tumor. Serum value of cytokeratin 19 was evaluated whether it is available for the diagnostic marker. Telomerase activity increased in malignant neoplasms were also studied in oral cancers and salivary gland tumors.
[Results]
Eleven bands with molecular weights of 40-58K were obtained after extraction of the normal salivary gland in 9.5 M urea-5% 2-mercaptoethanol solution. One-and two-dimensional electrophoretic analysis suggested the presence of CK5, CK7, CK8, CK13, CK14, CK15, CK17, CK18, and CK19 in the normal submandibular gland. Sixteen cytokeratin monoclonal antibodies were successfully developed. The reactivity to the salivary gland was different among the antibodies. Serum value of cytokeratin 19 increased to 6.3ng/ml in a patient with mucoepidermoid tumor. In contrast, it did not increase in 2 patients with adenoid cystic carcinoma. TeLomerase activity was suggested to be available for a diagnostic tumor marker of the malignant salivary gland tumor.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] 浜川 裕之、他: "ヒト顎下腺サイトケラチンの二次元電気泳動による解析" 日本口腔科学会雑誌. 44・3. 322-327 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroyuki Hamakawa, 他: "Histological evaluation of inducation chemotherapy with adriamycin,cysplatin and peplomycin on oral squamous cell carcinomas" Oral Oncology. 4. 164-167 (1995)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hamakawa H, 他: "Histological effects and predictive biomarkers of TPP induction chemotherapy for oral carcinoma" J.Oral Pathol Med. 26. (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroyuki Hamakawa, 他: "Cytokeratin Expression in squamous Cell carcinoma of the Lung and Oral Cavity:An immunocytochemical study with possible clinical relevance" Oral Surg Oral Pathol Oral Med. (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hamakawa H, 他: "Detection of Telomerase Activity in Oral Lesions" J Oral Pathol Med. 27. (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroyuki Hamakawa, 他: "Bone forming pleomorphic adenoma of the upper lip:Report of a case" J Oral Maxillofac Surg. 55. 1471-1475 (1997)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Hiroyuki Hamakawa: "Histological evaluation of induction chemotherapy with adriamycin, cysplatin and peplomycin on oral squamous cell carcinomas." Oral Oncology. 4. 164-167 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] I Tohnai: "Primary clinical effects of PP therapy (Cispalatin and Peplomycin) and TPP therapy (4'-O-tetrahydropyranyl-adriamycin, Cisplatin and Peplomycin) for oral cancer." Int J Clin Oncol. 1. 139-144 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiroyuki Hamakawa: "Bone forming pleomorphic adenoma of the upper lip.Report of a case" J Oral Maxillofac Surg. 55. 1471-1475 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hamakawa H: "Histological effects and predictive biomarkers of TPP induction chemotherapy for oral carcinoma." J Oral Pathol Med. 26 (in press). (1997)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Hiroyuki Hamakawa: "Cytokeratin Expression in Squamous Cell Carcinoma of the Lung and Oral Cavity : An immunocytochemical study with possible clinical relevance." Oral Surg Oral Pathol Oral Med. (in press). (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sumida T: "Detection of Telomerase Activity in Oral Lesions." J Oral Patol Med. 27 (in press). (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1999-03-16  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi